Macula Society (MS) 2023
Therapeutic effect of pegcetacoplan on RPE and photoreceptor integrity in GA in the phase Ill OAKS/DERBY trials
Pegcetacoplan in Geographic Atrophy: 24-Month Efficacy Results From the Phase 3 OAKS and DERBY Trials – Impact on Retinal Cells
24-Month Safety Results From the OAKS and DERBY Trials With Further Characterization of Exudative Age-Related Macular Degeneration
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.